A
Alaunos Therapeutics
0 followers
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy.
Org chart
Heidi Hagen
Interim CEO
Heidi Hagen
Collapse
Rafaele Baffa
Chief Medical Officer
Robert Hadfield
EVP, General Counsel, Secretary & Chief Compliance Officer
Eleanor De Groot
EVP & GM Cell Therapy
Jill Buck
EVP & GM Gene Therapy
Lynn M. Ferrucci
EVP of HR, Facilities, Administration & IT
Adam Levy
EVP of Investor Relations & Corporate Communications
Board & advisors
Chris Bowden
Director
Kevin Buchi
Director
James Huang
Director
Robert Postma
Director
Jaime Vieser
Director
Holger Weis
Director
Laurence J.N. Cooper
Scientific Advisor